Answers are grounded in this paper and cite their sources.
RYR2 and CASQ2 mutations are implicated in the pathogenesis of catecholaminergic polymorphic ventricular tachycardia, though genetic heterogeneity exists.
Catecholamine-induced polymorphic ventricular tachycardia (CPVT) is characterized by episodes of syncope, seizures, or sudden death in response to physical activity or emotional stress. The two modes of inheritance that have been described are autosomal dominant 1 and autosomal recessive. 2 Mutations in the ryanodine receptor 2 gene (RYR2), which encodes a cardiac sarcoplasmic reticulum Ca 2 release channel, were shown to cause the autosomal dominant form of the disease. 3 Recently, Priori et al 4 reported on clinical and molecular characterization of 30 probands with catecholaminergic polymorphic ventricular tachycardia and their 118 family members. A mutation screening of the RYR2 gene identified mutations in only 14 of 30 probands and in 9 family members.
No takes yet. Share an insight, caveat, or question.
Lahat et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: